Advanced NanoBiomed Research
Scope & Guideline
Exploring the Future of Nanobiotechnology
Introduction
Aims and Scopes
- Nanomaterials for Drug Delivery:
Research related to the design and application of nanomaterials as drug delivery systems, enhancing the efficacy and targeting of therapeutic agents. - Tissue Engineering and Regenerative Medicine:
Studies aimed at developing scaffolds and biomaterials for tissue regeneration, focusing on the interaction between cells and engineered materials. - Biosensing and Diagnostics:
Innovations in biosensing technologies utilizing nanomaterials for the detection of biomarkers, pathogens, and diseases. - Cancer Therapy and Immunotherapy:
Research on nanotechnology applications in cancer treatment, including targeted therapy, immunotherapy, and theranostics. - Biocompatible Materials:
Development of biocompatible materials that can interact safely with biological systems for various therapeutic applications. - Microfluidics and Organ-on-a-Chip Technologies:
Application of microfluidic systems for biological assays, drug testing, and modeling of human organs for biomedical research.
Trending and Emerging
- Smart and Responsive Nanocarriers:
Increased research on stimuli-responsive nanocarriers for targeted and controlled drug delivery, which allows for enhanced therapeutic effects and reduced side effects. - Biomimetic Materials:
A growing focus on materials that mimic biological systems, enhancing compatibility and functionality in biomedical applications. - Nanotechnology in Regenerative Medicine:
Emerging studies on the application of nanotechnology for regenerative medicine, including stem cell therapy and tissue repair mechanisms. - Machine Learning and AI in Nanomedicine:
The integration of machine learning and artificial intelligence to predict the behavior of nanomaterials and improve drug design processes is gaining traction. - Multi-Modal Therapeutic Approaches:
Research is increasingly focusing on combination therapies that integrate multiple modalities, including photothermal, photodynamic, and immunotherapy, to enhance cancer treatment outcomes.
Declining or Waning
- Traditional Drug Formulations:
Research focusing on conventional drug formulations and delivery methods seems to be less prevalent, with a shift towards more innovative nanotechnology-based approaches. - Basic Nanomaterial Properties:
Studies that primarily investigate the fundamental properties of nanomaterials without clear biomedical applications are becoming less common. - In Vivo Animal Studies:
There is a noticeable decrease in the number of publications emphasizing in vivo animal studies, as the focus shifts towards more advanced in vitro models and organ-on-a-chip technologies.
Similar Journals
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
Innovating the intersection of materials science and medicine.JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, published by WILEY, is a leading journal in the field of biomaterials and biomedical engineering, showcasing cutting-edge research that bridges the gap between material science and healthcare applications. With a robust 2023 impact factor reflecting its high-quality contributions, this journal is classified in the Q2 quartile for Biomaterials, Biomedical Engineering, and Ceramics and Composites, while achieving an impressive Q1 ranking in Metals and Alloys. The journal caters to a diverse readership, including researchers, professionals, and students, aiming to facilitate innovation and advancements in biocompatible materials and their applications in medical devices and tissue engineering. Access options for readers are available, ensuring the latest studies and findings are readily accessible to all stakeholders in this dynamic field. As it progresses towards its 2024 target, the JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A continues to be an essential resource for anyone involved in the development and application of biomedical materials.
ACS Biomaterials Science & Engineering
Fostering Innovation Through Rigorous Research and CollaborationACS Biomaterials Science & Engineering, published by the American Chemical Society, serves as a premier platform for the latest advancements and research in the fields of biomaterials and biomedical engineering. With an impressive impact factor and a strong reputation reflected in its ranking—Q2 in Biomaterials and Q1 in Biomedical Engineering—the journal attracts a diverse and engaged readership. Since its inception in 2015, it has aimed to foster innovation by publishing high-quality research articles, reviews, and perspectives on the synthesis, characterization, and application of biomaterials. Researchers and professionals benefit from the journal's rigorous peer-review process and its focus on translational science, making it essential for those looking to stay at the forefront of biomaterials research. Located in Washington, DC, USA, the journal plays a pivotal role in connecting academic and industrial sectors, ultimately driving advancements that impact biomedicine and related fields.
BIOMEDICAL MICRODEVICES
Bridging Engineering and Biology for Healthier FuturesBIOMEDICAL MICRODEVICES is a leading journal published by Springer that focuses on the innovative field of microdevices within biomedical engineering. With an ISSN of 1387-2176 and an E-ISSN of 1572-8781, BIOMEDICAL MICRODEVICES offers a prestigious platform for researchers to disseminate their findings from 1998 to 2024, demonstrating a long-standing commitment to advancing knowledge in this critical area. The journal is recognized for its significant contributions, boasting a Q2 ranking in Biomedical Engineering and Nanoscience and Nanotechnology, and a Q3 rank in Molecular Biology. Renowned for its rigorous peer-review process, it is positioned within the top 30% of its field according to Scopus rankings, making it a valuable resource for researchers and practitioners alike. Though it operates under a subscription model, the emphasis on quality and relevance within its scope ensures that BIOMEDICAL MICRODEVICES remains a vital source of cutting-edge research that bridges engineering and biological systems, fostering innovation and collaboration in the pursuit of novel health solutions.
ACS Applied Bio Materials
Advancing Knowledge in Biochemistry and Biomedical EngineeringACS Applied Bio Materials is a leading academic journal published by the American Chemical Society, focusing on the innovative intersection of bioengineering and materials science. Since its inception in 2018, the journal has established itself as a pivotal platform for disseminating impactful research within the fields of Biochemistry, Biomaterials, Biomedical Engineering, and Chemistry, often ranked in the top tiers of these categories. With an impressive impact factor, it holds a Q2 ranking in both Biochemistry and Biomaterials, and a prestigious Q1 ranking in Biomedical Engineering and miscellaneous Chemistry, underscoring its significance in advancing knowledge and practices across these disciplines. The journal’s editorial commitment to high-quality, peer-reviewed research ensures relevance and rigor, appealing to a diverse audience of researchers, professionals, and students keen to explore breakthroughs in bio-related materials technology. The access options enhance its visibility and reach, allowing for a broader dissemination of studies that drive innovation and collaboration in biotechnology and material sciences. Located in the heart of Washington, DC, ACS Applied Bio Materials serves as a crucial resource for advancing the future of healthcare, engineering, and materials research.
International Journal of Biomaterials
Transforming patient outcomes with pioneering biomaterials insights.The International Journal of Biomaterials, published by HINDAWI LTD, is a premier platform for disseminating groundbreaking research in the fields of biomaterials and biomedical engineering. With an Open Access approach since 2009, this journal provides unhindered access to innovative studies and applications aimed at advancing medical technologies and improving patient outcomes. Notably ranked in the Q3 category for both Biomaterials and Biomedical Engineering in 2023, it serves as an essential resource for researchers, practitioners, and students alike. The journal's Scopus rankings, including a 49th percentile in Biomedical Engineering and a 40th percentile in Biomaterials, further underscore its growing prominence in the academic community. With contributions spanning from 2011 to 2024, the journal seeks to foster collaborative research and promote developments that enhance the understanding and application of biomaterials in healthcare.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
Innovating healthcare through polymer science.JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, published by Taylor & Francis Ltd, is a distinguished scholarly journal dedicated to the exploration of biomaterials and their applications in various fields such as bioengineering, biomedical engineering, and biophysics. With an ISSN of 0920-5063 and an E-ISSN of 1568-5624, this journal offers a platform for researchers and professionals to share innovative findings and methodologies that advance the science of polymer-based biomaterials. The journal's impact within the academic community is underscored by its notable Scopus rankings, including a Q2 status in both Biomedical Engineering and Biophysics as of 2023, reflecting its significant contribution to advancing knowledge and practice in these fields. The scope of the journal spans from fundamental research to applications in medical devices and regenerative medicine, ensuring comprehensive coverage of the latest trends and breakthroughs. Although it does not currently offer open access options, the journal remains a pivotal resource for students, researchers, and professionals committed to the development and application of biomaterials in healthcare. For further details, the journal is based in Abingdon, United Kingdom, at 2-4 Park Square, Milton Park, OX14 4RN.
Biomaterials Advances
Unleashing Potential: The Next Wave of Biomaterials InnovationBiomaterials Advances is a premier journal published by Elsevier, dedicated to the rapidly evolving field of biomaterials. Established in the United Kingdom, this open-access journal aims to disseminate high-quality, peer-reviewed research that explores innovative biomaterial designs and their applications in bioengineering and biomedical engineering. With an impressive 2023 impact factor reflected in its Q1 rankings across multiple categories—including Bioengineering, Biomaterials, and Biomedical Engineering—Biomaterials Advances stands out as a critical platform for scholars and practitioners faced with advancing technologies and methodologies in the realm of materials science. Covering a broad range of topics, from biocompatibility to tissue engineering, this journal provides an inclusive forum for researchers seeking to contribute to the field. Its Scopus rankings further affirm its position as a leading resource, with notable standings in Biomedical Engineering (Rank #13), Biomaterials (Rank #8), and Bioengineering (Rank #11), all within the top percentiles. Researchers and students alike are encouraged to contribute and engage with the latest findings and innovations in biomaterials through this valuable publication.
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
Connecting Science and Medicine for a Healthier TomorrowJOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE is a leading peer-reviewed journal published by Springer, dedicated to advancing the field of biomedical materials science. With an ISSN of 0957-4530 and E-ISSN 1573-4838, this Open Access journal has been committed to providing researchers and professionals with freely accessible, high-quality research since 2021. It features an extensive scope spanning bioengineering, biomaterials, biomedical engineering, and biophysics, reflecting its significant impact within these interdisciplinary domains. Recognized within the Q2 category of the 2023 rankings in multiple fields, the journal proudly positions itself as a crucial resource for innovative materials that contribute to advancements in medical applications. With impressive Scopus rankings, including 26th in Biophysics and 40th in Materials Science for Biomaterials, researchers, students, and industry professionals alike can rely on this publication for cutting-edge insights that drive the future of medical materials and technologies. Based in Dordrecht, Netherlands, the journal provides a vibrant platform for sharing groundbreaking discoveries and fostering collaborative research among a global audience.
JOURNAL OF NANOBIOTECHNOLOGY
Exploring the Frontiers of Nanoscience and BiotechnologyJOURNAL OF NANOBIOTECHNOLOGY is a distinguished academic journal published by BMC in the field of nanobiotechnology, focusing on the intersection of nanoscience, biotechnology, and biomedical engineering. Since its inception in 2003, this open-access journal has played a pivotal role in disseminating high-quality research, becoming a leading platform for innovators and scholars alike. With a remarkable impact factor and consistently ranking in the Q1 category across multiple fields—including Applied Microbiology, Bioengineering, and Pharmaceutical Science—the journal demonstrates its critical relevance and influence in advancing knowledge and applications in nanobiotechnology. Furthermore, its impressive Scopus rankings reflect its commitment to rigorously peer-reviewed content, making it a go-to resource for researchers, professionals, and students striving to push the boundaries of science. Given its broad scope, covering emerging trends and technologies, JOURNAL OF NANOBIOTECHNOLOGY continues to foster collaboration and innovation across multidisciplinary fields, inviting submissions from across the globe.
Progress in Biomedical Engineering
Leading the charge in biomedical innovation and collaboration.Progress in Biomedical Engineering, published by IOP Publishing Ltd, is a premier open-access journal that serves as a vital platform for the dissemination of innovative research in the field of biomedical engineering. With an impressive Q1 classification in the Biomedical Engineering category for 2023, this journal has established itself as a significant contributor to the advancement of engineering solutions that improve healthcare outcomes. Recognized for its high-quality and impactful publications, it ranks 51st out of 303 in its field on Scopus, placing it in the 83rd percentile. The journal aims to foster interdisciplinary collaboration and introduce pioneering methodologies and technologies that bridge the gap between engineering and medicine. By providing a pathway for rapid communication of fundamental and applied research, Progress in Biomedical Engineering is dedicated to shaping the future of healthcare technology. Access to its content ensures that researchers, professionals, and students remain at the forefront of biomedical innovation.